Skip to content

What are the side effects of Tezepelumab ocular?

4 min read

According to the FDA label, allergic conjunctivitis is a potential side effect that can occur after receiving Tezepelumab (Tezspire). This guide details what are the side effects of Tezepelumab ocular, explaining the signs and symptoms to look for and when to seek medical advice for eye-related issues.

Quick Summary

Allergic conjunctivitis, eye irritation, and other ocular symptoms are potential side effects of the asthma medication Tezepelumab. Reactions can occur hours or days after injection and may signify a hypersensitivity response requiring medical attention.

Key Points

  • Allergic Conjunctivitis: A potential side effect of Tezepelumab, manifested by burning, itching, redness, or swelling of the eyes.

  • Delayed Reaction: Hypersensitivity reactions, including allergic conjunctivitis, can occur hours or days after receiving a Tezepelumab injection.

  • Not an Eye Medication: Tezepelumab is an injectable medication for severe asthma, and ocular effects are systemic side effects, not from direct application.

  • Seek Medical Advice: For mild eye symptoms, contact your doctor; for severe symptoms or signs of a serious allergic reaction, seek emergency care immediately.

  • Lower Ocular Risk than Dupilumab: Compared to Dupilumab, Tezepelumab is associated with a lower incidence of ocular side effects, though risks are still present.

  • Do Not Stop Abruptly: Never discontinue Tezepelumab without consulting a doctor, as it can worsen asthma symptoms.

In This Article

Tezepelumab (brand name Tezspire) is a biologic medication used as an add-on maintenance treatment for adults and pediatric patients aged 12 years and older with severe asthma. It works by blocking a protein called thymic stromal lymphopoietin (TSLP), which plays a key role in the inflammatory process of asthma. While effective for asthma management, patients and caregivers should be aware of potential side effects, including those affecting the eyes. Ocular side effects are primarily associated with hypersensitivity or allergic reactions to the medication.

Ocular Side Effects Associated with Tezepelumab

While Tezepelumab is not an eye medication, the systemic injection can lead to certain ocular side effects as part of a broader allergic or hypersensitivity response. The most commonly reported eye-related adverse event is allergic conjunctivitis, but other symptoms can also arise. These reactions can sometimes occur hours or even days after receiving the injection.

Allergic Conjunctivitis

Allergic conjunctivitis is an inflammation of the membrane covering the whites of the eyes (conjunctiva), caused by an allergic reaction. For individuals on Tezepelumab, this is a recognized hypersensitivity reaction. The symptoms can include:

  • Burning, dry, or itching eyes: A persistent or irritating sensation in the eyes.
  • Redness: The eyes may appear visibly red and inflamed.
  • Excessive tearing or watery discharge: The eyes may produce more tears than usual or have a noticeable discharge.
  • Swelling: Swelling of the eye or eyelid can occur.

Other Eye-Related Symptoms

In addition to allergic conjunctivitis, patients should be aware of other potential serious, though rare, eye symptoms that warrant immediate medical evaluation. These include:

  • Sudden vision loss
  • Blurred or tunnel vision
  • Eye pain or swelling
  • Seeing halos around lights

These more severe symptoms, along with other signs of a systemic allergic reaction such as breathing problems, hives, or swelling of the face, require immediate emergency medical care.

What to Do If You Experience Ocular Side Effects

It is crucial to follow your doctor's advice regarding any side effects experienced while on Tezepelumab. Here are general steps to take if you notice any eye-related issues:

  • Contact your healthcare provider: For mild to moderate symptoms like itching or redness, inform your doctor at your earliest convenience. They can help determine if the symptoms are related to the medication and advise on the next steps.
  • Seek immediate medical attention for severe symptoms: If you experience any severe eye symptoms, such as sudden vision changes or significant pain, or if you also have symptoms of a severe allergic reaction (anaphylaxis), seek emergency medical care immediately.
  • Do not stop treatment abruptly: Never discontinue Tezepelumab or any other asthma medication without consulting your doctor, as this could lead to a worsening of your asthma symptoms.

Comparing Ocular Side Effects: Tezepelumab vs. Dupilumab

While both Tezepelumab and Dupilumab are biologic medications for severe asthma, they have different mechanisms of action and reported side effect profiles, particularly concerning ocular issues. Dupilumab is a known cause of more frequent and sometimes more severe ocular side effects, which is a distinction worth noting for patients considering their treatment options.

Feature Tezepelumab (Tezspire) Dupilumab (Dupixent)
Mechanism of Action Blocks TSLP, a key upstream mediator of inflammation. Blocks IL-4 and IL-13, cytokines involved in Type 2 inflammation.
Common Ocular Side Effect Allergic conjunctivitis. Conjunctivitis (often with a higher incidence).
Reported Incidence Occurs as part of general hypersensitivity reactions; generally considered lower frequency than Dupilumab. Higher incidence rates reported in clinical studies, sometimes affecting a significant percentage of patients.
Symptom Profile Burning, dry, or itching eyes; redness; swelling. Conjunctivitis, dry eye, blepharitis, eye pruritus, keratitis.
Severity Hypersensitivity reactions can be serious, but ocular symptoms are often managed by a doctor. Ocular side effects can range from mild to less common but more severe conditions like ulcerative keratitis.

It is important to discuss these differences with your healthcare provider, especially if you have a history of ocular issues or are switching between biologic treatments. For more detailed safety information, consult the official FDA prescribing information for Tezspire.

Conclusion

While generally well-tolerated, Tezepelumab does carry a risk of ocular side effects, primarily allergic conjunctivitis, as a component of potential hypersensitivity reactions. The key to safe management is awareness of the symptoms, which include burning, itching, redness, and swelling of the eyes. Unlike some other biologic treatments like Dupilumab, Tezepelumab is not associated with a high incidence of eye-related issues, but it remains a possibility that patients should monitor. If you experience any concerning eye symptoms, whether mild or severe, it is imperative to communicate with your healthcare provider promptly. Following their guidance and reporting any adverse effects is the best way to ensure both effective asthma management and overall safety while on the medication.

Frequently Asked Questions

Ocular side effects with Tezepelumab are not considered common. They are generally reported as part of hypersensitivity reactions, which themselves are a less frequent but possible adverse event.

You should contact your healthcare provider if you experience eye irritation. Describe your symptoms so they can determine if it's related to the injection and advise on appropriate steps.

While rare, serious eye symptoms like blurred vision, sudden vision loss, or eye pain have been noted as requiring immediate medical attention. They are typically associated with severe allergic reactions.

Eye-related side effects, particularly allergic conjunctivitis, can appear anywhere from a few hours to several days after receiving a Tezepelumab injection.

If you experience eye irritation or conjunctivitis, you should stop wearing contact lenses and contact your doctor for advice. Your doctor can help you determine when it is safe to resume use.

Yes, other allergic reactions can occur, including rash, hives, swelling of the face, mouth, and tongue, and trouble breathing. These can also be signs of anaphylaxis, a serious medical emergency.

Clinical data suggests that Tezepelumab is associated with a lower incidence of ocular side effects compared to Dupilumab, another biologic medication for severe asthma.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.